Sunday, November 24, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
Precious Metals

Silver Alert. “Press the Pedal to the Metal.”

Editor / Curator -
Superbug News - CoronaVirus Watch List

Bill Gates Warns That a Next Pandemic Could Be 10 Times...

Editor / Curator -
Good Clinic, Biotech Stock Review
Biotech News

Mitesco (MITI) $0.45 to Open its First Medical Clinic.

Editor / Curator -
Psychedelic News

Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).

Editor / Curator -
Citius, Biotech Stock Review
2020 Watch List

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

Editor / Curator -
Mitesco, Biotech Stock Review, roland rick perry
2020 Watch List

Short Squeeze Mania.

Editor / Curator -
Stem Cells

Video: Pacific Stem Cell

Editor / Curator -
ENDRA, Biotech Stock Review
Biotech News

Heads UP: ENDRA Life Science (NDRA) $1.50, up 40% Today.

Editor / Curator -
Internet Stock Review
Bitcoin

Is the Bitcoin Bubble More Fraud Than Frenzy?

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
1...525354...93Page 53 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.